STAAR Surgical (STAA)
(Real Time Quote from BATS)
$39.70 USD
-1.82 (-4.38%)
Updated Jul 30, 2024 03:22 PM ET
3-Hold of 5 3
D Value B Growth B Momentum B VGM
Balance Sheet
Fiscal Year End for STAAR Surgical Company falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 221 | 212 | 200 | 152 | 120 |
Receivables | 95 | 62 | 44 | 35 | 31 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 35 | 24 | 17 | 18 | 17 |
Other Current Assets | 15 | 13 | 11 | 11 | 7 |
Total Current Assets | 365 | 312 | 271 | 216 | 175 |
Net Property & Equipment | 67 | 51 | 36 | 24 | 17 |
Investments & Advances | 12 | 14 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 5 | 5 | 4 | 5 | 4 |
Intangibles | 2 | 2 | 2 | 2 | 2 |
Deposits & Other Assets | 3 | 1 | 1 | 1 | 1 |
Total Assets | 489 | 415 | 346 | 257 | 207 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 1 | 2 |
Accounts Payable | 14 | 12 | 9 | 8 | 8 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 1 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 47 | 36 | 37 | 29 | 21 |
Total Current Liabilities | 65 | 52 | 49 | 41 | 34 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 1 | 1 | 1 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 5 | 2 | 9 | 12 | 8 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 103 | 83 | 87 | 60 | 47 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 437 | 404 | 374 | 338 | 304 |
Retained Earnings | -47 | -73 | -111 | -136 | -142 |
Other Equity | -4 | 0 | -4 | -6 | -3 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 386 | 332 | 259 | 197 | 160 |
Total Liabilities & Shareholder's Equity | 489 | 415 | 346 | 257 | 207 |
Total Common Equity | 386 | 332 | 259 | 197 | 160 |
Shares Outstanding | 48.80 | 48.20 | 47.60 | 46.10 | 44.50 |
Book Value Per Share | 7.91 | 6.89 | 5.43 | 4.28 | 3.59 |
Fiscal Year End for STAAR Surgical Company falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 245 | 221 | 188 | 192 |
Receivables | NA | 65 | 95 | 112 | 94 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 39 | 35 | 31 | 25 |
Other Current Assets | NA | 17 | 15 | 16 | 16 |
Total Current Assets | NA | 366 | 365 | 347 | 328 |
Net Property & Equipment | NA | 72 | 67 | 63 | 56 |
Investments & Advances | NA | 7 | 12 | 14 | 18 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 5 | 5 | 9 | 5 |
Intangibles | NA | 2 | 2 | 2 | 2 |
Deposits & Other Assets | NA | 6 | 3 | 2 | 1 |
Total Assets | NA | 493 | 489 | 472 | 441 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 17 | 14 | 9 | 11 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 42 | 47 | 44 | 39 |
Total Current Liabilities | NA | 63 | 65 | 57 | 54 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 1 | 1 | 1 | 1 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 5 | 3 | 3 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 100 | 103 | 93 | 87 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 448 | 437 | 436 | 420 |
Retained Earnings | NA | -51 | -47 | -55 | -64 |
Other Equity | NA | -5 | -4 | -3 | -3 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 393 | 386 | 379 | 354 |
Total Liabilities & Shareholder's Equity | NA | 493 | 489 | 472 | 441 |
Total Common Equity | 0 | 393 | 386 | 379 | 354 |
Shares Outstanding | 49.10 | 49.10 | 48.80 | 48.80 | 48.50 |
Book Value Per Share | 0.00 | 8.00 | 7.91 | 7.76 | 7.29 |